Hot Features
プレミアム
Travere Therapeutics Inc (TVTX)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Timothy P. CoughlinIndependent Director | -3.25k | 141.34k | Automatic Disposition | 43.49 | 52.25k | -5.86% |
| 2026-05-04 | Dr. William E. RoteChief Research Officer | -2.76k | 121.43k | Derivative Exercise and Sale | 43.95 | 65.87k | - |
| 2026-05-04 | Dr. William E. RoteChief Research Officer | 1.49k | 0.00 | Derivative Exercise and Retained Stock | - | 65.87k | 2.31% |
| 2026-05-04 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -24.25k | 733.46k | Derivative Exercise and Sale | 17.96 - 46.65 | 105.21k | - |
| 2026-05-05 | Dr. Roy D. BaynesIndependent Director | -4.50k | 127.71k | Derivative Exercise and Sale | 18.27 - 46.65 | 37.50k | - |
| 2026-05-04 | Mr. Jeffrey A. MecklerIndependent Director | -8.00k | 229.36k | Derivative Exercise and Sale | 16.33 - 45.00 | 87.50k | - |
| 2026-05-04 | Dr. Eric M. DubePresident, CEO & Director | -22.50k | 988.88k | Derivative Exercise and Sale | 43.95 | 152.37k | - |
| 2026-05-06 | Dr. Jula InrigChief Medical Officer | -311.00 | 13.67k | Automatic Disposition | 43.95 | 113.24k | -0.27% |
| 2026-05-05 | Dr. Jula InrigChief Medical Officer | -2.17k | 101.42k | 売り | 46.65 | 113.24k | -1.88% |
| 2026-05-04 | Dr. Jula InrigChief Medical Officer | -20.00k | 452.00k | Derivative Exercise and Sale | 22.40 - 45.00 | 113.24k | - |
| 2026-05-04 | Dr. Jula InrigChief Medical Officer | 4.25k | 0.00 | Derivative Exercise and Retained Stock | - | 113.24k | 3.90% |
| 2026-05-04 | Mr. Christopher ClineCFO | -2.49k | 115.37k | Derivative Exercise and Sale | 43.95 - 46.65 | 118.66k | - |
| 2026-05-04 | Mr. Christopher ClineCFO | 1.76k | 0.00 | Derivative Exercise and Retained Stock | - | 118.66k | 1.50% |
| 2026-05-04 | Mr. Peter HeermaChief Commercial Officer | -2.17k | 101.42k | Derivative Exercise and Sale | 46.65 | 85.05k | - |
| 2026-05-04 | Mr. Peter HeermaChief Commercial Officer | 2.08k | 0.00 | Derivative Exercise and Retained Stock | - | 85.05k | 2.50% |
| 2026-05-01 | Dr. Roy D. BaynesIndependent Director | -9.75k | 364.65k | Derivative Exercise and Sale | 6.82 - 44.22 | 37.50k | - |
| 2026-04-22 | Dr. William E. RoteChief Research Officer | -9.10k | 355.72k | Automatic Disposition | 39.09 | 60.21k | -13.13% |
| 2026-04-14 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -15.25k | 381.52k | Derivative Exercise and Sale | 8.93 - 41.07 | 42.35k | - |
| 2026-04-14 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -6.73k | 276.28k | Automatic Disposition | 41.07 | 42.35k | -13.71% |
| 2026-04-14 | Dr. Roy D. BaynesIndependent Director | -32.75k | 775.82k | Derivative Exercise and Sale | 15.43 - 42.12 | 37.50k | - |
| 2026-04-14 | Mr. Gary A. LyonsIndependent Chairman of the Board | -8.00k | 197.92k | Derivative Exercise and Sale | 16.33 - 41.07 | 57.50k | - |
| 2026-04-14 | Mr. Peter HeermaChief Commercial Officer | -7.22k | 302.52k | 売り | 41.93 | 78.80k | -8.39% |
| 2026-04-14 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -37.50k | 874.18k | Derivative Exercise and Sale | 15.46 - 41.07 | 105.21k | - |
| 2026-04-14 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -7.22k | 302.52k | 売り | 41.93 | 105.21k | -6.42% |
| 2026-04-15 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -6.79k | 283.81k | Automatic Disposition | 41.62 - 42.53 | 105.21k | -6.06% |
| 2026-04-15 | Dr. Eric M. DubePresident, CEO & Director | -64.00k | 2.63M | Automatic Disposition | 41.01 - 42.66 | 129.71k | -33.04% |
| 2026-04-14 | Dr. Jula InrigChief Medical Officer | -7.22k | 302.52k | 売り | 41.93 | 111.47k | -6.08% |
| 2026-04-15 | Dr. Jula InrigChief Medical Officer | -1.02k | 43.38k | Automatic Disposition | 42.61 | 111.47k | -0.90% |
| 2026-04-13 | Mr. Christopher ClineCFO | -7.30k | 305.40k | 売り | 28.85 - 41.93 | 116.90k | -5.88% |
| 2026-04-14 | Mr. Christopher ClineCFO | -1.02k | 43.58k | Automatic Disposition | 41.07 - 42.61 | 116.90k | -0.87% |
| 2026-04-06 | Dr. Roy D. BaynesIndependent Director | -10.00k | 64.80k | Derivative Exercise and Sale | 26.52 - 33.00 | 37.50k | - |
| 2026-04-01 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10.00k | 145.40k | Derivative Exercise and Sale | 15.46 - 30.00 | 105.21k | - |
| 2026-04-01 | Dr. Eric M. DubePresident, CEO & Director | -60.00k | 928.24k | Derivative Exercise and Sale | 15.46 - 31.46 | 129.71k | - |
| 2026-03-16 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10.00k | 90.06k | Derivative Exercise and Sale | 19.08 - 28.09 | 105.21k | - |
| 2026-02-20 | Dr. Eric M. DubePresident, CEO & Director | -60.00k | 878.17k | Derivative Exercise and Sale | 15.46 - 30.10 | 129.71k | - |
| 2026-02-17 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10.00k | 87.52k | Derivative Exercise and Sale | 19.08 - 28.26 | 105.21k | - |
| 2026-02-04 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -2.99k | 96.36k | Automatic Disposition | 32.07 - 32.74 | 105.21k | -2.77% |
| 2026-02-04 | Dr. Jula InrigChief Medical Officer | -1.78k | 57.30k | Automatic Disposition | 32.11 - 32.85 | 105.71k | -1.66% |
| 2026-02-04 | Mr. Christopher ClineCFO | -1.75k | 56.17k | Automatic Disposition | 32.14 - 32.90 | 111.23k | -1.54% |
| 2026-02-03 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -4.33k | 139.18k | 売り | 32.12 | 49.08k | -8.11% |
| 2026-02-03 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -7.18k | 230.46k | 売り | 32.12 | 108.21k | -6.22% |
| 2026-02-03 | Dr. William E. RoteChief Research Officer | -12.45k | 409.10k | Automatic Disposition | 32.87 | 55.31k | -18.37% |
| 2026-02-03 | Dr. Eric M. DubePresident, CEO & Director | -100.09k | 3.23M | Automatic Disposition | 32.06 - 32.70 | 129.71k | -43.55% |
| 2026-02-03 | Dr. Jula InrigChief Medical Officer | -6.96k | 223.43k | 売り | 32.12 | 107.49k | -6.08% |
| 2026-02-03 | Mr. Christopher ClineCFO | -7.24k | 232.61k | 売り | 32.12 | 112.97k | -6.02% |
| 2026-02-03 | Mr. Peter HeermaChief Commercial Officer | -7.31k | 234.80k | 売り | 32.12 | 72.02k | -9.22% |
| 2026-01-23 | Dr. Eric M. DubePresident, CEO & Director | -60.00k | 877.53k | Derivative Exercise and Sale | 15.46 - 30.10 | 129.71k | - |
| 2026-01-20 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10.00k | 82.62k | Derivative Exercise and Sale | 19.08 - 27.34 | 90.27k | - |
| 2026-01-05 | Dr. Jula InrigChief Medical Officer | -2.03k | 81.61k | 売り | 40.18 | 86.31k | -2.30% |
| 2026-01-06 | Dr. Jula InrigChief Medical Officer | -445.00 | 16.80k | Automatic Disposition | 37.75 | 86.31k | -0.51% |
| 2025-12-24 | Mr. Peter HeermaChief Commercial Officer | -4.98k | 199.20k | Automatic Disposition | 40.00 | 65.64k | -7.05% |
| 2025-12-24 | Dr. William E. RoteChief Research Officer | -60.00k | 1.17M | Derivative Exercise and Sale | 20.61 - 40.10 | 48.61k | - |
| 2025-12-24 | Dr. Jula InrigChief Medical Officer | -15.00k | 496.05k | Derivative Exercise and Sale | 8.93 - 42.00 | 88.79k | - |
| 2025-12-24 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -7.40k | 296.08k | Automatic Disposition | 40.00 | 38.23k | -16.22% |
| 2025-12-15 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -2.91k | 104.76k | Automatic Disposition | 36.00 | 45.64k | -5.99% |
| 2025-12-01 | Mr. Christopher ClineCFO | -20.00k | 375.60k | Derivative Exercise and Sale | 16.23 - 35.01 | 92.08k | - |
| 2025-11-04 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -61.25k | 733.79k | Derivative Exercise and Sale | 8.93 - 36.00 | 48.55k | - |
| 2025-11-04 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -5.87k | 211.14k | Automatic Disposition | 36.00 | 48.55k | -10.78% |
| 2025-10-31 | Mr. Timothy P. CoughlinIndependent Director | -18.00k | 325.56k | Derivative Exercise and Sale | 16.33 - 35.03 | 55.50k | - |
| 2025-10-31 | Mr. Peter HeermaChief Commercial Officer | -5.59k | 195.69k | Automatic Disposition | 35.00 | 70.62k | -7.34% |
| 2025-11-03 | Mr. Peter HeermaChief Commercial Officer | -1.08k | 0.00 | Other Disposition | - | 70.62k | -1.50% |
| 2025-10-28 | Dr. Eric M. DubePresident, CEO & Director | -120.00k | 1.78M | Derivative Exercise and Sale | 15.46 - 30.38 | 129.71k | - |
| 2025-10-28 | Mr. Peter HeermaChief Commercial Officer | -2.66k | 79.86k | Automatic Disposition | 30.00 | 77.29k | -3.33% |
| 2025-09-22 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10.00k | 59.20k | Derivative Exercise and Sale | 19.08 - 25.00 | 89.88k | - |
| 2025-09-23 | Mr. Peter HeermaChief Commercial Officer | -891.00 | 0.00 | Other Disposition | - | 79.95k | -1.10% |
| 2025-09-03 | Mr. Christopher ClineCFO | -454.00 | 8.26k | 売り | 18.20 | 92.08k | -0.49% |
| 2025-09-04 | Mr. Christopher ClineCFO | -119.00 | 2.35k | Automatic Disposition | 19.71 | 92.08k | -0.13% |
| 2025-08-27 | Mr. Christopher ClineCFO | -470.00 | 8.14k | Automatic Disposition | 17.31 | 92.66k | -0.50% |
| 2025-07-01 | Dr. Jula InrigChief Medical Officer | -815.00 | 11.94k | Automatic Disposition | 14.65 | 88.79k | -0.91% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
